Welgene Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	375.94	322.55	280.55	321.9	312.65
Revenue Growth (YoY)	16.55%	14.97%	-12.85%	2.96%	-21.46%
Cost of Revenue	219.76	186.71	160.83	180.1	179.38
Gross Profit	156.18	135.84	119.72	141.8	133.27
Selling, General & Admin	129.61	110.69	100.43	104.3	97.13
Research & Development	26.51	25.85	24.15	21.63	21.64
Operating Expenses	156.05	136.69	123.98	124.52	118.97
Operating Income	0.13	-0.85	-4.26	17.29	14.3
Interest Expense	-3.41	-2.97	-2.62	-0.28	-0.43
Interest & Investment Income	2.16	1.46	1.46	0.51	0.17
Earnings From Equity Investments	-	-	-	-	-2.89
Currency Exchange Gain (Loss)	-	0.25	0.01	-0.02	-
Other Non Operating Income (Expenses)	2.46	3	1.69	0.25	0.18
EBT Excluding Unusual Items	1.34	0.88	-3.73	17.74	11.34
Gain (Loss) on Sale of Investments	-	-	-	-4.19	5.04
Gain (Loss) on Sale of Assets	-	0.37	-0.11	-	0.21
Other Unusual Items	-	-	0.81	-	-
Pretax Income	1.34	1.25	-3.03	13.55	16.6
Income Tax Expense	0.04	0.54	0.11	4.01	2.89
Earnings From Continuing Operations	1.3	0.71	-3.15	9.54	13.7
Minority Interest in Earnings	0.03	0.4	0.5	0.01	-0
Net Income	1.33	1.11	-2.65	9.55	13.7
Net Income to Common	1.33	1.11	-2.65	9.55	13.7
Net Income Growth	20.14%	-	-	-30.29%	-53.98%
Shares Outstanding (Basic)	22	23	23	23	23
Shares Outstanding (Diluted)	22	23	23	23	23
Shares Change (YoY)	-4.88%	-	-0.10%	0.93%	10.99%
EPS (Basic)	0.06	0.05	-0.11	0.41	0.59
EPS (Diluted)	0.06	0.05	-0.11	0.41	0.59
EPS Growth	26.31%	-	-	-30.53%	-58.74%
Free Cash Flow	-6.08	51.27	-28.1	24.57	6.87
Free Cash Flow Per Share	-0.27	2.20	-1.21	1.05	0.30
Dividend Per Share	-	-	-	0.180	0.480
Dividend Growth	-	-	-	-62.50%	-56.44%
Gross Margin	41.54%	42.11%	42.67%	44.05%	42.63%
Operating Margin	0.03%	-0.27%	-1.52%	5.37%	4.57%
Profit Margin	0.35%	0.34%	-0.94%	2.97%	4.38%
Free Cash Flow Margin	-1.62%	15.90%	-10.02%	7.63%	2.20%
EBITDA	27.92	14.54	9.48	24.44	22.23
EBITDA Margin	7.43%	4.51%	3.38%	7.59%	7.11%
D&A For EBITDA	27.79	15.39	13.74	7.15	7.93
EBIT	0.13	-0.85	-4.26	17.29	14.3
EBIT Margin	0.03%	-0.27%	-1.52%	5.37%	4.57%
Effective Tax Rate	3.14%	43.52%	-	29.58%	17.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.